Company performance
Add to research
Current Price
as of Apr 25, 2025$14.17
P/E Ratio
N/A
Market Cap
$2.22B
Description
Add to research
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.
Metrics
Add to research
Overview
- HQRadnor, PA
- SectorTechnology Services
- IndustryPackaged Software
- TickerCERT
- Price$14.17-1.73%
Trading Information
- Market cap$2.22B
- Float75.04%
- Average Daily Volume (1m)2,870,447
- Average Daily Volume (3m)1,846,570
- EPS-$0.08
Company
- Revenue$385.15M
- Rev growth (1yr)8.70%
- Net income-$12.05M
- Gross margin45.97%
- EBITDA margin22.55%
- EBITDA$86.85M
- EV$1.84B
- EV/Revenue4.78
- P/EN/A
- P/S5.72
- P/B2.09
- Debt/Equity29.46
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset